| SC 13G | 2021-06-10 | HIRSCHMAN ORIN | SCYNEXIS INC | 1,345,394 | 6.5% | EDGAR |
| SC 13G/A | 2021-03-10 | FEDERATED HERMES, INC. | SCYNEXIS INC | 2,129,553 | 11.0% | EDGAR |
| SC 13G/A | 2021-02-16 | Avidity Partners Management LP | SCYNEXIS INC | 1,964,960 | 9.9% | EDGAR |
| SC 13G/A | 2021-02-16 | CAXTON CORP | SCYNEXIS INC | 1,474,370 | 7.5% | EDGAR |
| SC 13G/A | 2021-02-12 | Stonepine Capital Management, LLC | SCYNEXIS INC | 1,530,650 | 7.7% | EDGAR |
| SC 13G/A | 2021-02-12 | FEDERATED HERMES, INC. | SCYNEXIS INC | 2,129,553 | 19.5% | EDGAR |
| SC 13G/A | 2021-02-11 | Puissance Life Science Opportunities Fund VI | SCYNEXIS INC | 255,718 | 2.3% | EDGAR |
| SC 13G | 2021-01-27 | PERCEPTIVE ADVISORS LLC | SCYNEXIS INC | 1,300,000 | 6.8% | EDGAR |
| SC 13G | 2020-12-23 | Avidity Partners Management LP | SCYNEXIS INC | 1,086,706 | 9.9% | EDGAR |
| SC 13G | 2020-12-23 | Stonepine Capital Management, LLC | SCYNEXIS INC | 1,536,953 | 7.7% | EDGAR |
| SC 13G/A | 2020-02-14 | CAXTON CORP | SCYNEXIS INC | 7,936,111 | 8.2% | EDGAR |
| SC 13G/A | 2020-02-14 | FEDERATED HERMES, INC. | SCYNEXIS INC | 18,610,412 | 19.1% | EDGAR |
| SC 13G/A | 2020-02-14 | Puissance Life Science Opportunities Fund VI | SCYNEXIS INC | 126,865 | 0.0% | EDGAR |
| SC 13G | 2019-12-23 | Decheng Capital China Life Sciences USD Fund III, L.P. | SCYNEXIS INC | 5,555,556 | 5.8% | EDGAR |
| SC 13G | 2019-12-20 | ARMISTICE CAPITAL, LLC | SCYNEXIS INC | 6,222,778 | 5.7% | EDGAR |
| SC 13G | 2019-03-15 | Puissance Life Science Opportunities Fund VI | SCYNEXIS INC | 5,009,830 | 10.0% | EDGAR |
| SC 13G/A | 2019-02-14 | CAXTON CORP | SCYNEXIS INC | 4,325,000 | 9.0% | EDGAR |
| SC 13G/A | 2019-02-13 | Stonepine Capital Management, LLC | SCYNEXIS INC | 568,450 | 1.2% | EDGAR |
| SC 13G/A | 2019-02-13 | FEDERATED INVESTORS INC /PA/ | SCYNEXIS INC | 6,868,400 | 14.3% | EDGAR |
| SC 13G/A | 2019-02-12 | Sanofi | SCYNEXIS INC | 0 | 0.0% | EDGAR |